ConductScience.org, home

Paper36968140

Nanoparticle STING Agonist Reprograms the Bone Marrow to an Antitumor Phenotype and Protects Against Bone Destruction.

Florian DC and 10 others. Cancer Res Commun, 2023. Cited by 4 papers, by iCite.

Cite this record

ConductScience Library. Nanoparticle STING Agonist Reprograms the Bone Marrow to an Antitumor Phenotype and Protects Against Bone Destruction. Papers, record 36968140. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36968140

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Nanoparticle STING Agonist Reprograms the Bone Marrow to an Antitumor Phenotype and Protects Against Bone Destruction.
PubMed
Journal
Cancer Res Commun
PubMed
Year
2023
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, Non-P.H.S., Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
4
iCite
Relative citation ratio, by iCite
0.42
iCite
Revised in PubMed
2026-08-20
PubMed

Authors11

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
NeoplasmsMajor topic
NanoparticlesMajor topic
Mice
Animals
Bone Marrow
Cytokines
Phenotype
Tumor Microenvironment

Source PubMed

Download CSV of topics

Grants9

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
R01 CA245134NCI NIH HHSUnited StatesR01CA245134PubMed and NIHNIH RePORTER
I01 BX001957BLRD VAUnited StatesI01BX001957PubMed and NIHNIH RePORTER
U01 OH012271NIOSH CDC HHSUnited StatesU01OH012271PubMed and NIHNIH RePORTER
R01 CA262287NCI NIH HHSUnited StatesR01CA262287PubMed and NIHNIH RePORTER
IK6 BX006476BLRD VAUnited StatesIK6BX006476PubMedNIH RePORTER
T32 GM007347NIGMS NIH HHSUnited StatesT32GM007347PubMed and NIHNIH RePORTER
P30 CA068485NCI NIH HHSUnited StatesP30CA068485PubMed and NIHNIH RePORTER
F31 CA257275NCI NIH HHSUnited StatesF31CA257275PubMed and NIHNIH RePORTER
T32 GM152284NIGMS NIH HHSUnited StatesT32GM152284PubMedNIH RePORTER

Download CSV of grants

References76

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
125959818Direct Activation of STING in the Tumor Microenvironment Leads to Potent and Systemic Tumor Regression and Immunity.Cell Rep2015https://conductscience.org/library/papers/25959818PubMed
217763372Pathologic fractures correlate with reduced survival in patients with malignant bone disease.Cancer2007https://conductscience.org/library/papers/17763372PubMed
333189789Nanoparticle delivery improves the pharmacokinetic properties of cyclic dinucleotide STING agonists to open a therapeutic window for intravenous administration.J Control Release2021https://conductscience.org/library/papers/33189789PubMed
420704976Mechanisms of bone metastasis.Discov Med2004https://conductscience.org/library/papers/20704976PubMed
531477121Surgical stress and cancer progression: the twisted tango.Mol Cancer2019https://conductscience.org/library/papers/31477121PubMed
630973611Current Landscape of Immunotherapy in Breast Cancer: A Review.JAMA Oncol2019https://conductscience.org/library/papers/30973611PubMed
718305549The bone marrow niche: habitat to hematopoietic and mesenchymal stem cells, and unwitting host to molecular parasites.Leukemia2008https://conductscience.org/library/papers/18305549PubMed
830258983Liposomal Delivery Enhances Immune Activation by STING Agonists for Cancer Immunotherapy.Adv Biosyst2017https://conductscience.org/library/papers/30258983PubMed
921832278Vascular endothelial growth factor-induced elimination of the type 1 interferon receptor is required for efficient angiogenesis.Blood2011https://conductscience.org/library/papers/21832278PubMed
1025663076Liposomal delivery of dexamethasone attenuates prostate cancer bone metastatic tumor growth in vivo.Prostate2015https://conductscience.org/library/papers/25663076PubMed
1112177785The antitumour activity of 5,6-dimethylxanthenone-4-acetic acid (DMXAA) in TNF receptor-1 knockout mice.Br J Cancer2002https://conductscience.org/library/papers/12177785PubMed
1232796899Bone metastasis is associated with acquisition of mesenchymal phenotype and immune suppression in a model of spontaneous breast cancer metastasis.Sci Rep2020https://conductscience.org/library/papers/32796899PubMed
1329204985Comparison of the characteristics of macrophages derived from murine spleen, peritoneal cavity, and bone marrow.J Zhejiang Univ Sci B2017https://conductscience.org/library/papers/29204985PubMed
1434339645Trastuzumab for early-stage, HER2-positive breast cancer: a meta-analysis of 13 864 women in seven randomised trials.Lancet Oncol2021https://conductscience.org/library/papers/34339645PubMed
1530823602The Contribution of the Immune System in Bone Metastasis Pathogenesis.Int J Mol Sci2019https://conductscience.org/library/papers/30823602PubMed
1623307597Morphology and quantitative composition of hematopoietic cells in murine bone marrow and spleen of healthy subjects.Ann Hematol2013https://conductscience.org/library/papers/23307597PubMed
1732169869Potent STING activation stimulates immunogenic cell death to enhance antitumor immunity in neuroblastoma.J Immunother Cancer2020https://conductscience.org/library/papers/32169869PubMed
1830971820Developmental origin, functional maintenance and genetic rescue of osteoclasts.Nature2019https://conductscience.org/library/papers/30971820PubMed
1930779854Cyclic Dinucleotides Inhibit Osteoclast Differentiation Through STING-Mediated Interferon-β Signaling.J Bone Miner Res2019https://conductscience.org/library/papers/30779854PubMed
2034831167Mechanisms, Diagnosis and Treatment of Bone Metastases.Cells2021https://conductscience.org/library/papers/34831167PubMed

See all 76 referencesDownload CSV of references

Cited by6

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.

PMIDTitleJournalYearIn PapersSource
42902412Nanoengineered STING agonists for cancer therapy: toward immunodynamic control.J Hematol Oncol2026https://conductscience.org/library/papers/42902412PubMed
42798946Analysis of the heterogeneity of the immune microenvironment of bone metastases and new strategies of nanotechnology intervention.Oncol Rev2026https://conductscience.org/library/papers/42798946PubMed
42198265Nanoparticle Strategies for Bone Metastasis Immunotherapy: Targeting, Immune Reprogramming and Combination Therapy.Pharmaceutics2026https://conductscience.org/library/papers/42198265PubMed
42146389CPT1A loss promotes lung metastasis in immune-competent mice via a mechanism of mtDNA release and chronic activation of STING pathway.bioRxiv2026https://conductscience.org/library/papers/42146389PubMed
41150754Monitoring Pharmacological Treatment of Breast Cancer with MRI.Curr Issues Mol Biol2025https://conductscience.org/library/papers/41150754PubMed
37753868Engineering endosomolytic nanocarriers of diverse morphologies using confined impingement jet mixing.Nanoscale2023https://conductscience.org/library/papers/37753868PubMed

Download CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ITGAM3684PubTator's text mininghttps://conductscience.org/library/genes/3684NCBI Gene
STING1340061PubTator's text mininghttps://conductscience.org/library/genes/340061NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36968140

GET https://conductscience.org/api/papers/v1/36968140/references?page=2